Parts for roche cobas 6800 system which is a fully automated nucleic acid amplification platform that provides high throughput testing for a variety of diseases including hepatitis b and c, and is the…
Ended Awarded Last action
- Contract number
- HT001424F0143
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $218,119
Award facts
- Contract value 100% obligated
- $218,119.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 622110 General Medical and Surgical Hospitals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20889, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $218,119 |
About this award
This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is for the provision of parts for the Roche Cobas 6800 System, a fully automated nucleic acid amplification testing platform used for a variety of diseases including hepatitis B and C, as well as SARS-CoV-2. The contract, a Blanket Purchase Agreement (BPA) call, has a ceiling value of $218,119.26 and is set to run until February 28, 2025. The award was made by the Defense Health Agency, a defense agency, and does not have a set-aside designation. Roche Diagnostics, a foreign-owned, for-profit manufacturer, has a history of providing critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to various federal agencies through prime contracts and subcontracts.
Description
Parts for roche cobas 6800 system which is a fully automated nucleic acid amplification platform that provides high throughput testing for a variety of diseases including hepatitis b and c, and is the main testing platform for sars-COV-2
Quick answers
Who was awarded contract HT001424F0143?
HT001424F0143 was awarded to Roche Diagnostics Corporation by Defense Health Agency (Department of Defense) on September 27, 2024.
How much is contract HT001424F0143 worth?
The government has obligated $218,119 on HT001424F0143.
Is contract HT001424F0143 an order under another contract?
Yes. HT001424F0143 is a BPA call under HT001421A0001, a blanket purchase agreement.
Was contract HT001424F0143 competed?
The extent of competition for HT001424F0143 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award